drug
(ethinylestradiol + levonorgestrel)
Marketedupdated 4mo agoby Agile Therapeutics Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jul 10, 2028
~1.8 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (3)
- Aug 26, 2028formulationUS 82469782.0y
- Jul 10, 2028formulationUS 87478881.8y
- Jul 10, 2028formulationUS 90503481.8y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 56m ago
Found something off?
comments(0)
5-min edit window · permanent after that